Provider review
Bodybuilding Health+ review: it names its doctors, and tells you to expect full results in two months
Who is actually writing the prescription? Almost no seller answers that. Bodybuilding Health+ names two physicians, with their license numbers, and all four pharmacies that might fill your order. Then its own FAQ says full results develop over two to three months. The trials behind these drugs ran 68 and 72 weeks. Believe the timeline and you would conclude the medication had failed while the studies were still measuring gains.
Partner link — we may earn a commission. How we’re paid
Visit Bodybuilding Health+Of Bodybuilding Health+’s 2 dated product claims documented below, 0 are consistent with the cited evidence. Among the dated prices documented below, the lowest listed upfront charge is $179 for 30 days (Compounded semaglutide, one month). A matching claim does not mean the compounded product was tested or FDA-approved.
Names its two physicians and all four pharmacies, then tells you full results arrive in two to three months when the trials ran a year and a half.
Worth trusting if
- You want the doctor writing your prescription named and licensed, which is rare here
- You want to know which pharmacies might fill it, and to look each one up yourself
- You want the FDA disclosure about compounded medicines stated plainly, which it is
Be skeptical if
- You would take the two-to-three-month timeline as a deadline, because the trials ran far longer
- You want to know which of the four pharmacies will fill your order, which the site does not say
- You want a published price or a trial reference for its peptide and longevity products
Disclosure: Some links on this site are affiliate or referral links. If you start a treatment or buy a product through them, we may earn a commission at no additional cost to you. Read our full disclosure.
Compounded
Phase 3 trials
Named
None found
Provenance
Products reviewed at Bodybuilding Health+
These evidence cards classify the treatments evaluated in this review. Confirm the exact medicine and formulation proposed for your prescription with the care team.
Prepared by a state-licensed pharmacy against a prescription for a named patient. Compounded preparations are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality.
- Compounded semaglutide injection — $179 for a single month, falling to $141.50 across a year — a ladder that descends properly.
- Compounded tirzepatide injection — $209 a month. Watch the ladder: its twelve-month plan costs $187.33 against $174.67 for six.
Evidence
Has the molecule been tested for what it is sold for?
Each row summarizes human evidence for the molecule and the use being advertised. Results apply to the product, dose, population and outcome studied; they do not establish that this provider’s preparation or program produces the same results. Compounded drugs are not FDA-approved. Evidence for one use should not be assumed to support another.
2
Products with human evidence
For the advertised use, out of 2 products reviewed here. The evidence concerns the molecule, not Bodybuilding Health+'s service.
2
Registry records cited
Distinct ClinicalTrials.gov records cited across the reviewed products. Registration alone does not establish that a treatment works.
The comparison
What they claim, against what the trials show
Each claim below is quoted word for word from Bodybuilding Health+’s own page. Tap a row to see the quote, the trials behind it, and why it got that verdict.
Compounded semaglutide injectionSemaglutide · Compounded (503A)Claim reaches past the trials
“Consistent appetite control. Long-term weight management support. A structured, provider-guided program. Full results for most programs develop over 2–3 months of consistent use combined with provider-guided care.”
Read on the Bodybuilding Health+ site, September 2026
Phase 3 trials
What the trials show for Semaglutide
- NCT03548935 STEP 1 — Phase 3, completed, n=1,961. 68 weeks in 1,961 adults, titrated to semaglutide 2.4 mg. The mean reduction of about 15% is the result at the END of 68 weeks; weight was still falling well past month three.
Two to three months is not when full results arrive on this molecule. STEP 1 ran 68 weeks and reported its headline mean at the end of them, and the weight curve in that trial was still descending long after month three. The practical harm is the opposite of the usual one: most overstatements promise too much too soon and this one does too, but the specific risk here is that a patient measures themselves against a two-month deadline, finds they are nowhere near it, and stops. The rest of what Bodybuilding Health+ says about this product is careful — consistent appetite control and long-term weight management support are fair descriptions with no number attached, and the site states plainly that compounded medications have not been evaluated or approved by the FDA.1
Compounded tirzepatide injectionTirzepatide · Compounded (503A)Claim reaches past the trials
“Enhanced metabolic optimization. Appetite and portion control support. Long-term, results-driven care. Full results for most programs develop over 2–3 months of consistent use.”
Read on the Bodybuilding Health+ site, September 2026
Phase 3 trials
What the trials show for Tirzepatide
- NCT04184622 SURMOUNT-1 — Phase 3, completed, n=2,539. 72 weeks in 2,539 adults at 5, 10 and 15 mg once weekly. The roughly 21% mean is the result at the END of 72 weeks.
The same two-to-three-month timeline is applied to tirzepatide, whose trial ran even longer than semaglutide's at 72 weeks. Nothing else on this product overreaches — enhanced metabolic optimization and appetite support are descriptions rather than promises, and no percentage or pounds figure is attached anywhere. The timeline is the single claim that fails, and it fails on both molecules for the same reason: it describes a couple of months where the evidence describes a year and a half.2
Dispensing chain
Who actually fills your prescription
- Belmar Pharmacy
- Strive Pharmacy
- Epiq Scripts
- Casa Pharma Rx
Read the full account
This is the fullest answer to who-makes-it and who-prescribes-it in either of our registries, and it comes with a caveat worth reading. Bodybuilding Health+ names four pharmacies with telephone numbers and websites, and — rarer still — names the two physicians leading its medical group, with their license numbers. Almost nothing else we grade names an individual doctor at all. The caveat is that one of those four pharmacies received an FDA warning letter in March 2023 about products that failed the rules for pharmacy compounding, including the use of ingredients that were not eligible and suppliers that were not registered. That letter concerns the pharmacy and not this company, the other three screened clean, and the site does not say which pharmacy fills a given order — so a buyer can read the disclosure and still not know which one they will get.
Read on the Bodybuilding Health+ site, September 2026.
Quality
Third-party testing, and what is published
Describes a testing regime
Not established in this source review
Certificate of analysis readable
A readable lot report was not verified here
Read the full testing account
No certificate of analysis, potency, purity or sterility result is published. The site does state plainly that compounded medications have not been evaluated or approved by the FDA for safety, efficacy or quality, which is the right disclosure in the right words. Its review counts are unsourced — 146 on the semaglutide product, 117 on tirzepatide and more than 200 claimed overall — with no dates and no provider named. The strongest thing it publishes in place of test data is the supply chain itself: four named pharmacies a reader can look up, which is how the FDA letter against one of them became findable at all.
Read on the Bodybuilding Health+ site, September 2026.
Licensing
Licensed to dispense, and where
Coverage
Bodybuilding Health+ says it serves patients in all fifty states, adding that availability of specific services may vary by state based on provider licensure and applicable regulations. That answer sits inside a collapsed panel on the homepage rather than on the page itself, read in September 2026.
Read the full licensing claim
The company is named in the footer — Dynamo Group LLC, at 1 Town Center Road Suite #675, Boca Raton, Florida — and the medical group and its two lead physicians are named in the FAQ, with license numbers. That combination of a named company and named clinicians is unusual here.
Read on the Bodybuilding Health+ site, September 2026.
Regulatory
The FDA warning letter
No FDA warning letter found
Assessment
What holds up, and what does not
- It names the two physicians leading its medical group, with their license numbers.
- It names all four pharmacies that might fill your prescription, with phone numbers and websites.
- It states plainly that compounded medications have not been evaluated or approved by the FDA.
Show 4 more
- Its product descriptions attach no weight-loss percentage or pounds figure to either molecule.
- It publishes its company name and a Florida street address.
- It says coverage can vary by state rather than claiming fifty states without qualification.
- No FDA warning letter against the company itself.
- It says full results develop in two to three months; the trials behind these drugs ran 68 and 72 weeks.
- That timeline is applied to both molecules, including the one whose trial ran longest.
- One of its four named pharmacies received an FDA warning letter in 2023 about how it compounded products.
Show 5 more
- It does not say which of the four pharmacies fills a given order.
- The doctors, the pharmacies and the state coverage are all inside collapsed panels you must click to open.
- Its review counts are unsourced and undated.
- Its peptide and longevity products carry no published price and no trial reference.
- Its twelve-month tirzepatide plan costs $187.33 a month against $174.67 on the six-month one.
Verdict
The bottom line
Take the disclosure and leave the timeline. Knowing your prescriber's name and your pharmacy's phone number is worth more than most of what this market publishes — it is what made the warning letter findable at all. Then ignore the two-to-three-month promise. On the published evidence these drugs were still working well past a year, and treating month three as a verdict is how people quit something that was working.
Opens Bodybuilding Health+'s website. A link is not a recommendation to take anything.
Confirm which prescription you would receive
The October 13 public catalog distinguishes topical GHK-Cu from injectable products including PT-141. A skin-cream offer and an injectable offer should not be compared as if they were the same route, supply or clinical indication. The homepage describes assessment, provider review and ongoing check-ins; these are advertised services rather than experiences we have tested. 3
Its footer says a patient can specify another licensed pharmacy. Before relying on that option, ask whether changing pharmacies changes the medication cost, shipping or membership charges. Also obtain the next renewal date and refund cutoff; a visible starting price does not settle those terms.
Full analysis — 3 more sectionsIt answers the question nobody answers · And then the timeline · What the disclosure bought us
It answers the question nobody answers
Open the FAQ on Bodybuilding Health+ and you get this:
"Lion MD: A trusted team of nationwide medical professionals led by Dr. Ana Lisa Carr MD and Dr. Kelly Tenbrink MD."
With both license numbers. And then:
"We are proudly partnered with premier pharmacies: Belmar Pharmacy, Strive Pharmacy, Epiq Scripts, and Casa Pharma Rx."
With a phone number and a website for each.
Almost nothing else we grade names an individual doctor. Most name no pharmacy either. This is the fullest supply-chain and prescriber disclosure in either of our registries.
(All of that sits in collapsed panels, and opening one closes the others. Open them one at a time and every answer is there in full.)
And then the timeline
From the same FAQ:
"Full results for most programs develop over 2–3 months of consistent use combined with provider-guided care."
STEP 1 ran 68 weeks. 1 SURMOUNT-1 ran 72 weeks. 2 Both reported their headline figures at the end of those periods, and in both the weight curve was still descending long after month three.
Two to three months is roughly a sixth of either trial.
The risk here is not the usual one. Most exaggerated claims lead someone to expect too much. This one sets a deadline — and a patient who measures themselves against month three, finds they are nowhere near "full results", and concludes the medication has failed, would be quitting at the point the trials were still recording gains.
What the disclosure bought us
Naming your pharmacies is a real commitment, because it makes them checkable.
In March 2023 the FDA wrote to Belmar Pharma Solutions — the company behind Belmar Pharmacy, which Bodybuilding Health+ lists as one of its four — about drug products that "failed to meet the conditions of section 503A" — the rule that governs a pharmacy making a drug to order for one named patient — including compounding with ineligible bulk drug substances and using suppliers not registered with the FDA.
That letter is about the pharmacy, not about this company, and we found nothing against the other three. But the site does not say which pharmacy fills a given order, so a buyer can read all of this and still not know which one they are getting.
This is the trade a seller makes by naming names, and on balance it is the right one. You cannot check a company that tells you nothing.
Questions
Frequently asked questions
How long until I see results?
Longer than this site suggests. Its FAQ says full results develop over two to three months; the trials behind these drugs ran 68 and 72 weeks and reported their headline figures at the end of those periods. Treat month three as an early checkpoint, not a verdict.
Who writes the prescription?
A named physician — the site names both doctors leading its medical group and publishes their license numbers, which almost nothing else we grade does. You will need to open the collapsed panel on the homepage to see it.
Which pharmacy fills it?
One of four, and it names all of them with phone numbers and websites: Belmar Pharmacy, Strive Pharmacy, Epiq Scripts and Casa Pharma Rx. What it does not say is which one you will get for a given order.
Should the FDA letter worry me?
It is worth reading before you order. In March 2023 the FDA wrote to Belmar Pharma Solutions about products that failed the rules for pharmacy compounding, including ingredients that were not eligible and suppliers that were not registered. The letter concerns that pharmacy rather than this company, and we found nothing against the other three.
Is this the big Bodybuilding retail website?
The site never says so. It trades as Bodybuilding Health+, its company is Dynamo Group LLC in Boca Raton, and that retailer's name appears nowhere on it. The affiliate listing pointing here does carry that name, which is a fact about the listing rather than the company.
Glossary
Key terms
Show definitions
- STEP 1
- The phase 3 trial of once-weekly semaglutide 2.4 mg for weight loss — 1,961 adults over 68 weeks, published in the New England Journal of Medicine in 2021.
- SURMOUNT-1
- The phase 3 trial of once-weekly tirzepatide for weight loss — 2,539 adults over 72 weeks at 5, 10 and 15 mg, published in the New England Journal of Medicine in 2022.
- Compounded
- Made to order by a pharmacy for an individual patient rather than manufactured and approved as a finished product. Compounded drugs are not FDA-approved and the FDA has not evaluated their safety, effectiveness or quality.
- Bulk drug substance
- The raw active ingredient a compounding pharmacy starts from. US rules limit which substances may be used and require suppliers to be registered — the two things the 2023 letter to one of this seller's pharmacies concerned.
Compare
Others selling what Bodybuilding Health+ sells
Companies we have also reviewed that dispense at least one of the same compounds, ordered by how much of what they say about their products matches the trials behind them. Nothing here is a recommendation, and none of these links earns us anything.
Ranked
The lists Bodybuilding Health+ is on
Method
How we checked this
Non-product facts last checked September 2026. Read the editorial policy for the rules this page is held to.
Read our methodology
Claims read first-party
Every quoted claim was read off Bodybuilding Health+'s own pages, first-hand, on the date stamped against it — never from a summary, an aggregator, or an earlier version of this review.
Trials read from the registry
Phase, status and enrollment come from ClinicalTrials.gov; identifiers and journals from PubMed's own records. Nothing here is cited from memory.
Absence claims bounded
Where we report that no trial exists, the page says what was searched, where, and when — never an unbounded claim that nobody has tested something.
Letters matched on full name
FDA letters are matched on the complete company name. A substring match would attach one firm's regulatory history to another with a similar name.
Sources
References
Show all 3 sources
- Wilding JPH, Batterham RL, Calanna S, et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1) — 1,961 adults over 68 weeks, mean weight reduction of about 15% reported at the end of the trial. New England Journal of Medicine. https://clinicaltrials.gov/study/NCT03548935
- Jastreboff AM, Aronne LJ, Ahmad NN, et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1) — 2,539 adults over 72 weeks at 5, 10 and 15 mg once weekly. New England Journal of Medicine. https://clinicaltrials.gov/study/NCT04184622
- Publisher (2026). Public buyer information checked October 13, 2026. Public primary source. the Bodybuilding Health+ site
Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.